Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03502512 · ClinicalTrials.gov registry record · NA
REVOLVE or PureGraft Technique in Processing Fat Grafts for Patients Undergoing Breast Reconstruction
A NA study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT03502512: Completed NA study, sponsored by M.D. Anderson Cancer Center.
NCT03502512 is a NA study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03502512, a NA study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This trial studies how well REVOLVE or PureGraft technique works in processing fat grafts for patients who are undergoing breast reconstruction. During breast reconstructive surgery that uses autologous fat grafting (transplanting fat tissue from one part of your body to another), fat tissue is removed from the body (usually the abdomen, buttock, or thighs) and injected into another part of the body. This tissue must be "processed" (sometimes referred to as "washed" or "prepared") before being inserted back into the body. It is not yet known whether REVOLVE or PureGraft technique may work better in retaining graft fat after surgery.
Interventions
- OTHER Questionnaire Administration
- PROCEDURE Reconstructive Surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2018-02-13 |
| Est. Completion | 2021-08-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03502512
The ClinicalTrials.gov registry entry for NCT03502512 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Questionnaire Administration is the first listed.
NCT03502512 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03502512 about?
NCT03502512 is a clinical study titled "REVOLVE or PureGraft Technique in Processing Fat Grafts for Patients Undergoing Breast Reconstruction". This trial studies how well REVOLVE or PureGraft technique works in processing fat grafts for patients who are undergoing breast reconstruction. During breast reconstructive surgery that uses autologous fat grafting (transplanting fat tissue from one part of your body to another), fat tissue is remo...
What is the current status of trial NCT03502512?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2018-02-13. Estimated completion is 2021-08-06.
What interventions are being tested in trial NCT03502512?
The interventions under investigation include: Questionnaire Administration (OTHER), Reconstructive Surgery (PROCEDURE).
Who is sponsoring clinical trial NCT03502512?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.